Page 4 - Graphite Bio News Today

Grogan joins Biogen following a decades-long career in biopharma, including leadership roles at Genentech and Graphite Bio.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Graphite Bio, Inc. (NASDAQ:GRPH – Get Free Report) saw a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 990,500 shares, a decrease of 13.1% from the July 31st total of 1,140,000 shares. Based on an average daily trading volume, of 151,000 shares, the days-to-cover […]

03.08.2023 - Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today reported financial results for the second quarter ended ...

Graphite Bio, Inc. (NASDAQ:GRPH – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Graphite Bio in a note issued to investors on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer anticipates that the company will post earnings of ($0.61) per share for the year. […]

Shares of Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) have received an average recommendation of “Reduce” from the nine ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the company. The average twelve-month target price among […]

Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointment of Alethia Young as its new Chi...

(RTTNews) - Biopharmaceutical company Bicycle Therapeutics plc (BCYC) announced on Friday that it has appointed Alethia Young as its chief financi...

Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) saw a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 672,500 shares, a drop of 11.8% from the May 15th total of 762,400 shares. Based on an average daily volume of 125,900 shares, the days-to-cover ratio is […]

Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 672,500 shares, a drop of 11.8% from the May 15th total of 762,400 shares. Based on an average daily trading volume, of 125,900 shares, the short-interest ratio is presently 5.3 […]